Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 649

    1.

    Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells.

    Moens K, Berger V, Ahn JM, Van Schravendijk C, Hruby VJ, Pipeleers D, Schuit F.

    Diabetes. 2002 Mar;51(3):669-75.PMID: 11872665 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors.

    Moens K, Flamez D, Van Schravendijk C, Ling Z, Pipeleers D, Schuit F.

    Diabetes. 1998 Jan;47(1):66-72.PMID: 9421376 [PubMed - indexed for MEDLINE]Related articles

    3.

    Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.

    Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S.

    Diabetes Care. 1996 Aug;19(8):857-63.PMID: 8842604 [PubMed - indexed for MEDLINE]Related articles

    4.

    Evidence that glucagon stimulates insulin secretion through its own receptor in rats.

    Kawai K, Yokota C, Ohashi S, Watanabe Y, Yamashita K.

    Diabetologia. 1995 Mar;38(3):274-6.PMID: 7758872 [PubMed - indexed for MEDLINE]Related articles

    6.

    Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.

    Parkes DG, Pittner R, Jodka C, Smith P, Young A.

    Metabolism. 2001 May;50(5):583-9.PMID: 11319721 [PubMed - indexed for MEDLINE]Related articles

    7.

    Glucagon-like peptide-1 is a physiological incretin in rat.

    Wang Z, Wang RM, Owji AA, Smith DM, Ghatei MA, Bloom SR.

    J Clin Invest. 1995 Jan;95(1):417-21.PMID: 7814643 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans.

    Sreenan SK, Mittal AA, Dralyuk F, Pugh WL, Polonsky KS, Roe MW.

    Metabolism. 2000 Dec;49(12):1579-87.PMID: 11145120 [PubMed - indexed for MEDLINE]Related articles

    9.

    Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.

    Delmeire D, Flamez D, Hinke SA, Cali JJ, Pipeleers D, Schuit F.

    Diabetologia. 2003 Oct;46(10):1383-93. Epub 2003 Sep 17.PMID: 13680124 [PubMed - indexed for MEDLINE]Related articles

    10.

    Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.

    García-Flores M, Zueco JA, Alvarez E, Blázquez E.

    Eur J Biochem. 2001 Feb;268(3):514-20.PMID: 11168389 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets.

    Colombo M, Gregersen S, Xiao J, Hermansen K.

    Pancreas. 2003 Aug;27(2):161-6.PMID: 12883265 [PubMed - indexed for MEDLINE]Related articles

    12.

    Glucagon receptors on human islet cells contribute to glucose competence of insulin release.

    Huypens P, Ling Z, Pipeleers D, Schuit F.

    Diabetologia. 2000 Aug;43(8):1012-9.PMID: 10990079 [PubMed - indexed for MEDLINE]Related articles

    13.

    Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway.

    Jimenez-Feltstrom J, Lundquist I, Salehi A.

    Cell Tissue Res. 2005 Feb;319(2):221-30. Epub 2004 Nov 19.PMID: 15558323 [PubMed - indexed for MEDLINE]Related articles

    14.

    Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.

    Fehmann HC, Habener JF.

    FEBS Lett. 1991 Feb 25;279(2):335-40.PMID: 1672112 [PubMed - indexed for MEDLINE]Related articles

    15.

    Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.

    Vilsbøll T, Toft-Nielsen MB, Krarup T, Madsbad S, Dinesen B, Holst JJ.

    Diabetes Care. 2000 Jun;23(6):807-12.PMID: 10841001 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.

    Delmeire D, Flamez D, Moens K, Hinke SA, Van Schravendijk C, Pipeleers D, Schuit F.

    Biochem Pharmacol. 2004 Jul 1;68(1):33-9.PMID: 15183115 [PubMed - indexed for MEDLINE]Related articles

    17.

    Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness.

    Islam MS, Rahman SA, Mirzaei Z, Islam KB.

    Life Sci. 2005 Jan 28;76(11):1239-48. Epub 2004 Dec 8.PMID: 15642594 [PubMed - indexed for MEDLINE]Related articles

    18.

    Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas.

    Fehmann HC, Göke B, Göke R, Trautmann ME, Arnold R.

    FEBS Lett. 1989 Jul 31;252(1-2):109-12.PMID: 2668027 [PubMed - indexed for MEDLINE]Related articles

    19.

    Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction.

    Fehmann HC, Bode HP, Ebert T, Karl A, Göke B.

    Horm Metab Res. 1997 Nov;29(11):572-6.PMID: 9479558 [PubMed - indexed for MEDLINE]Related articles

    20.

    Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.

    Kolligs F, Fehmann HC, Göke R, Göke B.

    Diabetes. 1995 Jan;44(1):16-9.PMID: 7813808 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data